Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2007-04-13 | Mr. Alvino currently works as Managing Director for SCO Financial Group LLC. He previously worked at Feinstein Kean Healthcare, an Ogilvy Public Relations Worldwide Company. |
| 2008-04-22 | Mr. Alvino was Managing Director for SCO Financial Group LLC from July 2002 to May 2007. |
| 2009-04-22 | Mr. Alvino was a member of the board of directors of MacroChem Corporation from May 2007 until February 2009. |
| 2010-04-16 | Mr. Mark J. Alvino became a director in March 2006 initially as a designee of SCO Capital Partners LLC and is chairman of the Audit and Finance Committee. |
| 2011-04-14 | Mr. Alvino’s qualifications to serve our Board include his leadership skills and his experience in the areas of financial management and business strategy. |
| 2012-04-16 | Mr. Alvino is currently Managing Director for Griffin Securities and has been in this position since 2007. |
| 2013-04-02 | Mr. Alvino is currently Managing Director for Griffin Securities and has been in this position since 2007. |
| 2014-04-15 | Mr. Alvino is currently leading the LifeSciences efforts of Bradley Woods, & Co. Ltd. and has been in this position since 2013. |
| 2015-04-07 | Mr. Alvino's qualifications to serve our Board include his leadership skills and his experience in the areas of financial management and business strategy. |
| 2016-04-06 | Mr. Alvino is currently with Hudson Square Capital LLC since October 2014. |
| 2017-04-11 | Mr. Alvino’s qualifications to serve our Board include his leadership skills and his experience in the areas of financial management and business strategy in the biopharmaceutical field. |
| 2018-04-10 | Mr. Alvino’s qualifications to serve our Board include his leadership skills and his experience in the areas of financial management and business strategy. |
| 2019-04-11 | Mr. Alvino’s qualifications to serve on our Board include his leadership skills and his experience in the areas of financial management and business strategy. |
| 2020-04-10 | Mr. Alvino’s qualifications to serve on our Board include his leadership skills and his experience in the areas of financial management and business strategy in the biopharmaceutical field. |
| 2021-04-09 | Mark J. Alvino, 53, became a director on March 26, 2021 and currently serves as Chair of the Compensation Committee and as a member on the Audit Committee. |
| 2022-05-12 | Directors and Named Executive Officers: Mark J. Alvino |
| 2022-07-11 | Mr. Alvino is currently President of Hudson Square Capital LLC. |
| 2023-04-13 | Mark J. Alvino, 55, became a director on March 26, 2021 and currently serves as Chair of the Compensation Committee and as a member on the Audit Committee. |
| 2024-03-19 | Mark J. Alvino, 56, became a director on March 26, 2021 and currently serves as Chair of the Compensation Committee and as a member on the Audit Committee. |
| 2024-11-12 | The table below represents the compensation paid to each of our directors who served on the Board during the year ended December 31, 2023. |
Data sourced from SEC filings. Last updated: 2025-07-01